Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

BACKGROUND: Randomised controlled trials have evaluated the recombinant tetravalent dengue vaccine (CYD-TDV). However, individual results may have little power to identify differences among the populations studied. OBJECTIVE: To evaluate efficacy, immunogenicity and safety of CYD-TDV in the preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosa, Bruno Rodrigues, da Cunha, Antonio José Ledo Alves, Medronho, Roberto de Andrade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Evidence Based Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429993/
https://www.ncbi.nlm.nih.gov/pubmed/30872537
http://dx.doi.org/10.1136/bmjopen-2017-019368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429993/
https://www.ncbi.nlm.nih.gov/pubmed/30872537
http://dx.doi.org/10.1136/bmjopen-2017-019368

Ejemplares similares